Systems for modulating inflammation
First Claim
Patent Images
1. A system comprising:
- at least one drug delivery device configured to retain and dispense at least one therapeutic composition to at least one subject; and
one or more instructions that when executed on a computing device cause the computing device to regulate dispensing of the at least one drug delivery device,wherein the delivery device includes at least one therapeutic composition including at least one first agent configured to modulate the activity of one or more Toll-like receptors;
at least one second agent configured to modulate the activity of one or more Src family kinases; and
at least one third agent configured to modulate the activity of one or more NF-kB molecules.
1 Assignment
0 Petitions
Accused Products
Abstract
Certain embodiments disclosed relate to compositions, including therapeutic compositions, methods, devices, and systems that modulate at least one inflammatory response or reaction. According to various embodiments, the compositions, methods, devices, and systems relate to modulating one or more of Toll-like receptors, Src family kinases, NF-kB molecules, proteases, or proteasomes.
65 Citations
25 Claims
-
1. A system comprising:
-
at least one drug delivery device configured to retain and dispense at least one therapeutic composition to at least one subject; and one or more instructions that when executed on a computing device cause the computing device to regulate dispensing of the at least one drug delivery device, wherein the delivery device includes at least one therapeutic composition including at least one first agent configured to modulate the activity of one or more Toll-like receptors; at least one second agent configured to modulate the activity of one or more Src family kinases; and at least one third agent configured to modulate the activity of one or more NF-kB molecules. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)
-
Specification